LONDON & SAN FRANCISCO--(BUSINESS WIRE)--Today, Latent Labs launches Latent-Y, an AI agent that autonomously designs therapeutic antibodies from a text prompt, compressing weeks of expert work into hours. Powered by Latent-X2, Latent Labs' frontier model for drug-like antibody and peptide design, Latent-Y brings structural drug design to any researcher — no specialist infrastructure required. Latent Labs is opening access to selected partners. Latent-Y is a force multiplier for drug discovery t
2026 Copyright © News-Matic.com. All Rights Reserved
